Birkerod, Denmark

Ole Wiborg

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Dispersome IP Aps. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ole Wiborg. Retrieved from https://idiyas.com/inventor/ole-wiborg-ky5ph9j8

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ole Wiborg: Innovator in Co-Amorphous Drug Forms

Introduction

Ole Wiborg is a notable inventor based in Birkerod, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of co-amorphous forms of drug substances. His innovative work has the potential to enhance the efficacy of drug formulations.

Latest Patents

Wiborg holds a patent for "Co-amorphous forms of beta-lactoglobulin and a drug substance." This invention relates to co-amorphous forms of a drug substance and a protein, specifically beta-lactoglobulin. The purity of the beta-lactoglobulin in this co-amorphous form is at least 92% (w/w) of the total amount of protein. The invention also encompasses compositions, including pharmaceutical formulations, that utilize this co-amorphous form.

Career Highlights

Throughout his career, Ole Wiborg has worked with various companies, including Dispersome IP Aps and Zerion Pharma Aps. His experience in these organizations has contributed to his expertise in pharmaceutical innovations.

Collaborations

Wiborg has collaborated with notable professionals in his field, including Korbinian Löbmann and Donglei Leng. These partnerships have likely enriched his research and development efforts.

Conclusion

Ole Wiborg's contributions to the pharmaceutical industry, particularly through his patent on co-amorphous drug forms, highlight his role as an innovator. His work continues to influence the development of effective drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…